Calidi Biotherapeutics (Calidi Biotherapeutics) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Calidi Biotherapeutics's Free Cash Flow for the three months ended in Mar. 2024 was $-3.84 Mil. Calidi Biotherapeutics's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Calidi Biotherapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Calidi Biotherapeutics's current FCF Yield % is -30.80%.

The historical rank and industry rank for Calidi Biotherapeutics's FCF Margin % or its related term are showing as below:

During the past 4 years, the highest FCF Margin % of Calidi Biotherapeutics was -1777.28%. The lowest was -30315.56%. And the median was -16046.42%.

CLDI's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.

Calidi Biotherapeutics FCF Margin % Historical Data

The historical data trend for Calidi Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics FCF Margin % Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-1,777.28

-30,315.56

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Calidi Biotherapeutics's FCF Margin %

For the Biotechnology subindustry, Calidi Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calidi Biotherapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calidi Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Calidi Biotherapeutics's FCF Margin % falls into.

Calidi Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Calidi Biotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-27.568	/	0
	=	%

Calidi Biotherapeutics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-3.836	/	0
	=	%

Calidi Biotherapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024